24.00SEK-2.04%Mkt Cap: 80.64M $P/E: —1d ago
Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products in…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Avg
1M Perf
Lower
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap80.64M $
Enterprise Value44.37M $
Revenue (TTM)1.70M $
Gross Profit1.10M $
Net Income (TTM)61.15M $
Revenue/Share0.0490 USD
Last Price24.00 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees65
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.61
PEG13.07
EV/EBITDA-1.53
EV/Revenue26.06
P/S47.36
P/B2.31
EPS (TTM)-12.02
EPS (Forward)-4.28
52W Range
17.5025% of range43.40
52W High43.40 SEK
52W Low17.50 SEK
Profitability
Gross Margin44.23%
Oper. Margin-1514.00%
EBITDA Margin0.00%
Profit Margin2458.85%
ROE130.31%
ROA49.07%
Growth
Revenue Growth-62.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.69M $
CapEx (TTM)—
FCF Margin-0.84%
FCF Yield-0.02%
Net Debt-36.27M $
Net Debt/EBITDA1.25
Balance Sheet
Debt/Equity1.00
Current Ratio2.02
Quick Ratio1.97
Book Value/Sh10.38 SEK
Cash/Share10.99 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)29.00 SEK
Upside (mean)+20.8%
Target Range29.00 SEK – 29.00 SEK
# Analysts1
Ownership
Shares Out.35.13M
Float21.45M
Insiders18.89%
Institutions40.24%
Technical
SMA 5020.14 (+19.2%)
SMA 20026.13 (-8.2%)
Beta0.89
S&P 52W Chg20.05%
Avg Vol (30d)37.56K
Avg Vol (10d)33.46K
Technical Indicators
RSI (14)71.9
MACD1.0118
MACD Signal0.5932
MACD Hist.+0.4186
BB Upper24.45 SEK
BB Middle21.00 SEK
BB Lower17.55 SEK
BB Width32.88%
ATR (14)1.213 SEK
Vol Ratio (20d)0.98x